Publication summary

This paper outlines the aims of SEDRIC and highlights areas for action. Surveillance and epidemiology are central in the control of antibiotic resistance. There is a clear need to intensify the generation, collection, collation and distribution of high-quality epidemiological data. SEDRIC (Surveillance and Epidemiology of Drug Resistant Infections Consortium) was established to improve surveillance and aims to strengthen the availability of information needed to monitor and track the spread of resistance. SEDRIC has brought together experts to promote the use of evidence to inform the design of effective public health interventions and changes in policy globally.

Who this is for

  • Policy makers and civil servants working in AMR
  • AMR surveillance and epidemiology specialists
  • Pharmaceutical industry

Key findings

  • We need to identify barriers to effective surveillance.
  • There is a great need for technological innovation to develop standardised and harmonised data collection tools.
  • We must maximise data use from private and public organisations to inform policy-making on surveillance and epidemiology of antimicrobial resistance (AMR).

Access via 'The National Center for Biotechnology Information'